Clinical Trials | April 22, 2026
Moderna launches late-stage trial of mRNA bird flu vaccine
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
The conclave brought together key stakeholders from across the assisted living ecosystem
Subscribe To Our Newsletter & Stay Updated
